Sanofi SA SAN-FR:Euronext Paris

*Data is delayed | EUR
Last | 11/26/21 CET
85.01quote price arrow down-1.64 (-1.89%)
Volume
3,118,500
52 week range
74.92 - 91.14
Loading...
  • Open85.27
  • Day High86.29
  • Day Low84.28
  • Prev Close86.65
  • 52 Week High91.14
  • 52 Week High Date08/23/21
  • 52 Week Low74.92
  • 52 Week Low Date03/03/21

Key Stats

  • Market Cap120,313.82M
  • Shares Out1,252.54M
  • 10 Day Average Volume1.74M
  • Dividend3.20
  • Dividend Yield3.76%
  • Beta0.52
  • YTD % Change8.02

KEY STATS

  • Open85.27
  • Day High86.29
  • Day Low84.28
  • Prev Close86.65
  • 52 Week High91.14
  • 52 Week High Date08/23/21
  • 52 Week Low74.92
  • 52 Week Low Date03/03/21
  • Market Cap120,313.82M
  • Shares Out1,252.54M
  • 10 Day Average Volume1.74M
  • Dividend3.20
  • Dividend Yield3.76%
  • Beta0.52
  • YTD % Change8.02

RATIOS/PROFITABILITY

  • EPS (TTM)4.92
  • P/E (TTM)17.28
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/05/2021
  • Div Amount3.20
  • Split Date-
  • Split Factor-

Profile

MORE
Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment...
Serge Weinberg
Non-Executive Chairman
Paul Hudson Ph.D.
Chief Executive Officer
Jean- Baptiste Chasseloup De Chatillon
Chief Financial Officer
Karen Linehan J.D.
Executive Vice President
John Reed M.D., Ph.D.
Executive Vice President
Address
54 rue la Boetie
Paris
75008
France